• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[小细胞支气管癌的化疗]

[Chemotherapy of small cell bronchial carcinoma].

作者信息

Rainer H

出版信息

Onkologie. 1984 Oct;7(5):276-84. doi: 10.1159/000215461.

DOI:10.1159/000215461
PMID:6096782
Abstract

Many cytotoxic agents exhibit response in oat cell lung cancer. According to response rates those substances my be divided into 3 subgroups. Combination of chemotherapeutic drugs is considerable more active as compared to single agent therapy. Actuarial survival was significantly improved by chemotherapy and is related to dosages and the absolute number of cytotoxics used. Sequential chemotherapy with sequential administration of non-cross resistant schemes seems to be the optimal therapeutic strategy at present time. A ten-fold increase of survival has been shown including a small percentage of long term survivors. It seems likely to assume that those therapies combined in an optimal manner without dose-reductions during induction therapy will further improve survival and percentage of long term survivors.

摘要

许多细胞毒性药物对燕麦细胞肺癌有反应。根据反应率,这些物质可分为3个亚组。与单药治疗相比,化疗药物联合使用的活性明显更高。化疗显著提高了精算生存率,且与所用细胞毒性药物的剂量和绝对数量有关。采用非交叉耐药方案序贯给药的序贯化疗似乎是目前最佳的治疗策略。生存率提高了10倍,包括一小部分长期存活者。似乎可以假定,那些在诱导治疗期间以最佳方式联合使用且不减量的治疗方法将进一步提高生存率和长期存活者的比例。

相似文献

1
[Chemotherapy of small cell bronchial carcinoma].[小细胞支气管癌的化疗]
Onkologie. 1984 Oct;7(5):276-84. doi: 10.1159/000215461.
2
[Chemotherapy in cancer of the lung].[肺癌的化疗]
MMW Fortschr Med. 2006 Jun 1;148(22):33-4.
3
[Intensive chemotherapy treatment of small-cell bronchial cancer].[小细胞支气管癌的强化化疗治疗]
Rev Med Brux. 1990 Apr;11(4):96-108.
4
Innovations in multimodality therapy for lung cancer. Combined modality management of limited small-cell lung cancer.肺癌多模态治疗的创新。局限期小细胞肺癌的联合治疗管理。
Chest. 1993 Jan;103(1 Suppl):56S-59S.
5
Chemotherapeutic results in small cell lung cancer.小细胞肺癌的化疗结果
Recent Results Cancer Res. 1985;97:127-45. doi: 10.1007/978-3-642-82372-5_12.
6
[Perspectives on chemotherapy of cancer of the bronchi].[支气管癌化疗的展望]
Rev Mal Respir. 1989;6(5):409-16.
7
[Role of carboplatin in the treatment of lung cancer].
Bull Cancer. 2000 Aug;87 Spec No:34-9.
8
[Current treatment of small-cell anaplastic bronchial cancer (II)].[小细胞间变性支气管癌的当前治疗方法(二)]
Rev Med Chir Soc Med Nat Iasi. 1986 Jan-Mar;90(1):27-30.
9
Decreased metastasis and improved survival with early thoracic radiotherapy and prophylactic cranial irradiation in combined-modality treatment of limited-stage small cell lung cancer.在局限期小细胞肺癌的综合治疗中,早期胸部放疗和预防性颅脑照射可减少转移并提高生存率。
Radiat Oncol Investig. 1998;6(5):226-32. doi: 10.1002/(SICI)1520-6823(1998)6:5<226::AID-ROI4>3.0.CO;2-H.
10
Recent advances in chemotherapy for lung cancer.肺癌化疗的最新进展。
Curr Opin Pulm Med. 1996 Jul;2(4):285-9.